
Tesamorelin
TSM2 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to QuoteAnswer-first product list with quote-ready specifications and research-use boundaries.

TSM2 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SMO5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FMP2 2 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
OT2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FM2 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IGF-DES 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IP2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
G75 75iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IGF1 1 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IG01 0.1 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
H10 10iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HGH15 15 iu
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
H10 10 iu x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FRAG12 12 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GND2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HX2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
G210 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
G65 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GDF-8 1 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CD2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CND2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CJCIPA510 10 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CND2 2 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CP10 10 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CP20 20 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CP10 10 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
ACE0311 1 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AAW10 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote